EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML

EHA Library, Simge Kelekci, 386935

COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK

EHA Library, Mariela Muraru, 386936

SELINEXOR COMBINED WITH CX-4945 PROMOTES CELL DEATH BY TARGETING PIK3CD/AKT1/FOXO3 SIGNALING IN ACUTE MYELOID LEUKEMIA

EHA Library, Huideng Long, 386937

REAL LIFE APPLICATION OF NEXT GENERATION SEQUENCING IN ACUTE MYELOID LEUKEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Giulia Gabrielli, 386938

CO-MUTATION PROFILE IN A REAL-LIFE COHORT OF ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Giovanna Piras, 386939

REGULATORY MECHANISMS AND THERAPEUTIC POTENTIAL OF THE DLK1-DIO3 LOCUS IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA

EHA Library, Lonneke Verboon, 386940

THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)

EHA Library, Chi-Yang Tseng, 386941

ADDITIONAL СYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)

EHA Library, Olena Zotova, 386942

RUNX1 GERMLINE VARIANT AND CLONAL EVOLUTION TO ACUTE MYELOID LEUKEMIA – A FPDMM FAMILY STUDY

EHA Library, Maria Luís Amorim, 386943

THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION

EHA Library, Eduardo Anguita, 386944

PROGNOSTIC VALUE OF NEOPLASTIC INFLAMMATION AND CYTOKINES IN THE COURSE OF ACUTE MYELOID LEUKEMIA WITH MATURATION

EHA Library, Vira Barilka, 386945

KMT2A::ARHGEF12 RARE FUSION ASSOCIATED WITH A NOVEL GERMLINE DDX41 VARIANT IN ACUTE MYELOID LEUKEMIA

EHA Library, Maxime ROUBINET, 386946

THE EFFECT OF CONVENTIONAL CHEMOTHERAPY AFTER EXITING QUIESCENT STATE IN ACUTE MYELOID LEUKAEMIA

EHA Library, Daniel Láinez-González, 386947

THE INFLUENCE OF BCL2, BAX, BAX/BCL2 RATIO AND MDR1 GENE EXPRESSION ON PROGNOSIS OF ADULT DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

EHA Library, Zlatko Pravdic, 386948

INHIBITION OF THE DNA DAMAGE RESPONSE: A POSSIBLE NEW ROUTE IN ACUTE MYELOBLASTIC LEUKEMIA TREATMENT

EHA Library, Ana Bela Sarmento-Ribeiro, 386949

THE BONE MARROW MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA: THE ROLE OF MESENCHYMAL STEM CELLS AND THEIR IMPACT ON THE CLINICAL OUTCOME

EHA Library, Ludovica Calabretta, 386950

IDENTIFYING GENE TARGETS FOR DRUG REPURPOSING TO COUNTER MYELOID LEUKEMIA IN CHILDREN WITH DOWN-SYNDROME (ML-DS)

EHA Library, Anna-Lena Schmell, 386951

CELLULAR AND MOLECULAR CHARACTERIZATION OF THE ANTINEOPLASTIC EFFECTS OF CEPHALOCHROMIN IN MODELS OF ACUTE MYELOID LEUKEMIA

EHA Library, Mariane Cristina Do Nascimento, 386952

TWO-LEVEL INHIBITION OF HEDGEHOG SIGNALLING PATHWAY TO EXIT QUIESCENT STATE IN ACUTE MYELOID LEUKAEMIA

EHA Library, Daniel Láinez-González, 386953

REALGAR (AS4S4), A TRADITIONAL CHINESE MEDICINE, INDUCES ACUTE PROMYELOCYTIC LEUKEMIA CELL DEATH VIA THE BCL-2/BAX/CYT-C/AIF SIGNALING PATHWAY IN VITRO

EHA Library, Zonghong Li, 386954

QUERCETIN EXHIBITS ANTI-LEUKEMIA EFFECTS VIA REGULATION OF METABOLIC REPROGRAMMING

EHA Library, Jing Zhang, 386955

THE PROGNOSTIC AND PATHOGENETIC SIGNIFICANCE OF СOMPONENTS OF NEOPLASTIC INFLAMMATION AND CYTOKINES IN THE ADULT WITH ACUTE LEUKEMIA

EHA Library, Vira Barilka, 386956

THE BALANCE BETWEEN STAT3 ISOFORMS AS ESSENTIAL FEATURE IN ACUTE MYELOID LEUKEMIA

EHA Library, Stefanie Weiss, 386957

INFLAMMATION INDUCED COAGULATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Olivera Mitrović Ajtić, 386958

STREAMLINED WORKFLOW FOR ANALYZING AND REPORTING OPTICAL GENOME MAPPING FOR HEMATOLOGICAL MALIGNANCIES IN BIONANO VIA SOFTWARE

EHA Library, Alicia Bertolotti, 386959

ACQUIRED FACTOR VII DEFICIENCY ASSOCIATED WITH ACUTE MYELOID LEUKEMIA

EHA Library, Haifa Hafsa, 386960

SHENGMA BIEJIA DECOCTION,A TRADITIONAL CHINESE MEDICINE PRESCRIPTION,INDUCES LEUKEMIA CELLS MITOCHONDRIAL AUTOPHAGY VIA MITOCHONDRIAL DIVISION WAY.

EHA Library, Siyuan Cui, 386961

LOSS OF HETEROZYGOSITY IN AML PATIENTS WITH INV(16)

EHA Library, Dmitry Bessmertniy, 386962

ANTIBIOTICS; A POSSIBLE ALTERNATE TREATMENT OPTION FOR MYELOID LEUKEMIA

EHA Library, Dilawar Khan, 386963

BIOCHEMICAL ANALYSIS OF TRANSCRIPTION FACTOR PROTEIN-PROTEIN INTERACTIONS FOR INHIBITOR DESIGN

EHA Library, Paul Weiland, 386964

CYTOGENETIC PROFILE OF ACUTE MYELOBLASTIC LEUKEMIA TREATED AT THE MOHAMMED V MILITARY HOSPITAL IN RABAT (MOROCCO).

EHA Library, MOUSSA BOUH HAWA, 386965

OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER TREATMENT WITH VENETOCLAX/HYPOMETHYLATING AGENTS

EHA Library, Sabine Kayser, 386966

NUCLEOLIN INTERACTS WITH NUCLEOPHOSMIN AS A PREDICTOR OF PROGNOSIS IN ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Marta Pereira, 386967

DONOR-DERIVED CLL-1 CHIMERIC ANTIGEN RECEPTOR T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA BRIDGING TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT

EHA Library, Hai Yi, 386968

REAL: A RETROSPECTIVE STUDY OF THE CLINICO-BIOLOGICAL FEATURES OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS INCLUDED IN AN EARLY PHASE TRIAL AT A COMPREHENSIVE CANCER CENTER.

EHA Library, Guillaume BERTON, 386969

A MULTIOMIC, SINGLE-CELL MEASURABLE RESIDUAL DISEASE (SCMRD) ASSAY FOR PHASING DNA MUTATIONS AND SURFACE IMMUNOPHENOTYPES

EHA Library, Charlie Murphy, 386970

MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS

EHA Library, Ares Guardia-Torrelles, 386971

A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Maher Abdul-Hay, 386972

IN VITRO CHEMOSENSITIVITY ASSAY PREDICTS TREATMENT RESPONSE IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Yigeng Cao, 386973

EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE

EHA Library, Carla Borst, 386974

MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION COMBINED WITH CLAG REGIMEN IN REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA (NON-M3)

EHA Library, Kai Wan, 386975

COMPARISON OF CLINICAL CHARACTERISTICS OF ADULT CHILEAN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML), ACCORDING TO THEIR HEALTH CARE SYSTEM: ANALYSIS WITHIN THE FRAMEWORK OF THE PTHEMA AML REGISTRY

EHA Library, Monica Romero, 386976

OUTCOMES REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA WITH EXTRAMEDULLARY MANIFESTATIONS AFTER GEMTUZUMAB OZOGAMICIN THERAPY

EHA Library, Bella Ayubova, 386977

EARLY SEVERE ADVERSE EVENTS OF ACUTE MYELOID LEUKEMIA THERAPY DEPENDING ON THE INDUCTION THERAPY REGIMEN

EHA Library, Evgeniy Mikhailov, 386978

USE OF MACHINE LEARNING MODEL TO IDENTIFY PATIENTS RECEIVING OPTIMAL TREATMENT AND THE ASSOCIATED NON-BIOLOGICAL FACTORS: A POPULATION-BASED STUDY

EHA Library, Kueshivi Midodji ATSOU, 386979

MUTATION STATUS AND ALLELE BURDEN OF FLT3-ITD IN ACUTE MYELOID LEUKEMIA

EHA Library, Asiyat Radzhabova, 386980

VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IN OLDERLY OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Xiao Han, 386981

PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS.

EHA Library, Federica Lessi, 386982

DNMT3A MUTATION PATTERNS AND CLINICAL FEATURES IN KOREAN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Eunyoung Lee, 386983

HIGH EFFICACY OF HYPOMETHYLATING AGENTS PLUS VENETOCLAX COMBINATION THERAPY IN ELDERLY PATIENTS AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY: A REAL-LIFE EXPERIENCE.

EHA Library, MARIA ELENA ZANNIER, 386984

EFFICACY AND TOXICITY OF VENETOCLAX PLUS HYPOMETHYLATING AGENTS IN THE REAL LIFE OF ACUTE MYELOID LEUKEMIA

EHA Library, Gianluca Martini, 386985

VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT

EHA Library, Ryosuke Naka, 386986

VENETOCLAX AND HYPOMETHYLATING AGENT BASED OUTPATIENT AML INDUCTION- COST-EFFECTIVE METHOD FOR LMICS-REAL WORLD DATA FROM A TERTIARY CARE CENTER

EHA Library, Priyanka Chauhan, 386987

IMPROVED LONG-TERM SURVIVAL OF ELDERLY ADULTS WITH AML RECEIVING INTENSIVE INDUCTION THERAPY FOLLOWED BY EITHER ALLOGENEIC STEM CELL TRANSPLANT OR MAINTENANCE DIFFERENTIATIVE THERAPY

EHA Library, Federica Di Biase, 386988

NPM1-MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS

EHA Library, Chiara Sartor, 386989

IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60

EHA Library, Elena Parovichnikova, 386990

ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – REAL-LIFE EXPERIENCE IN THE REDEFINITION OF EUROPEAN LEUKEMIANET RISK CLASSIFICATION

EHA Library, Rita S Gomes, 386991

COMPARISON OF MYELOBLAST CELL PERCENTAGE IN INVESTIGATIONS  FOR ACUTE MYELOID LEUKAEMIA INCLUDING FLOW CYTOMETRY, BONE MARROW ASPIRATION AND BONE MARROW TREPHINE

EHA Library, Naml Iftikhar, 386992

FACTORS ASSOCIATED WITH OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: RENEHOC REGISTRY STUDY.

EHA Library, Claudia Lucía Sossa, 386993

HIGH RATES OF INFECTION AND RELATED MORALITY FROM VENETOCLAX THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE RETROSPECTIVE STUDY

EHA Library, Durga Chandran, 386994

SELINEXOR IN COMBINATION WITH VENETOCLAX AND HYPOMETHYLATING AGENTS FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE CO-MORBIDITIES

EHA Library, Fangli Chen, 386995

OUTCOMES OF PATIENTS WITH POSSIBLE GERMLINE AND SOMATIC CEBPA-MUTATED ACUTE MYELOID LEUKEMIA BASED ON VARIANT ALLELE FREQUENCY (VAF): A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Victor Ling, 386996

NON-HEMATOPOIETIC CELL TRANSPLANT-RELATED VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) IN SOLID TUMOR AND HEMATOLOGIC MALIGNANCIES: A SYSTEMATIC REVIEW

EHA Library, Lin Fan, 386997

SIXTEEN YEARS OF EXPERIENCE WITH THE MRC-10 PROTOCOL FOR THE TREATMENT OF ADULT ACUTE MYELOID LEUKEMIA IN THE SOUTH OF TUNISIA

EHA Library, Yousra Fakhfakh Derbel, 386998

EFFECTS OF VENETOCLAX-BASED COMBINATIONS FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA IN CLINICAL SETTINGS

EHA Library, Young Seob Park, 386999

MYELOID SARCOMA IN CHILDREN: ABOUT 9 CASES

EHA Library, Ameni Yahia, 387000

EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES

EHA Library, Beatrice Manghisi, 387001

ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – A DIFFERENT ENTITY IN THE ELDERLY?

EHA Library, Rita S Gomes, 387002

BONE MARROW LYMPHOCYTES AND SUBPOPULATION: A NOVEL PROGNOSTIC INDICATOR IN ACUTE MYELOID LEUKEMIA

EHA Library, NAHLA IBRAHIM, 387003

IMPLANTATION AND LONG-TERM USE OF PERIPHERALLY-INSERTED CENTRAL CATHETER ARE SAFE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKAEMIA

EHA Library, Tomáš Szotkowski, 387004

ENGAGING INNATE IMMUNITY: A PHASE 1 DOSE ESCALATION STUDY TO ASSESS SAFETY AND TOLERABILITY OF AFM28 MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Montserrat Arnan, 387005

PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7+3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Amer Zeidan, 387006

REAL WORLD EXPERIENCE OF VENETOCLAX-AZACYTIDINE COMBINATION IN FRAIL ELDERLY PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY

EHA Library, Muhammad Naim bin Che Rahimi, 387007

STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417

EHA Library, Pau Montesinos, 387008

TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Naval Daver, 387009

KB-LANRA 1001: A PHASE 1B/2 STUDY ON SAFETY, PK, PD, AND PRELIMINARY EFFICACY OF THE SELECTIVE SYK INHIBITOR LANRAPLENIB IN COMBINATION WITH THE FLT3 INHIBITOR GILTERITINIB, IN FLT3-MUTATED R/R AML

EHA Library, Anand Patel, 387010

TRIAL IN PROGRESS: A PHASE II STUDY OF MIDOSTAURIN COMBINED WITH INDUCTION/CONSOLIDATION CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN PEDIATRIC PATENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Dirk Reinhardt, 387011

EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA

EHA Library, asma koubaa, 387012

INCREASED INCIDENCE OF SRSF2 MUTATION WITH AGE INDICATING CLONAL HAEMATOPOIESIS IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Chrishthuka Kangatharan, 387013

CLONAL EVOLUTION WITH BCL-2 AMPLIFICATION DURING VENETOCLAX TREATMENT

EHA Library, Jorge Rodríguez-Afonso, 387014

NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS

EHA Library, Christos Varelas, 387015

CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA

EHA Library, asma koubaa, 387016

ACUTE MYELOID LEUKEMIA (AML): REAL-WORLD DATA FROM LEBANON

EHA Library, Lewis Nasr, 387017

GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULTS

EHA Library, Mehmet Hilmi Dogu, 387018

FIVE-YEAR REAL-WORLD DATA ON ACUTE MYELOID LEUKEMIA: RETROSPECTIVE STUDY FROM PUBLIC HEALTH CENTER IN BRAZIL

EHA Library, Marco Salvino, 387019

OUTCOMES OF PATIENTS UNDERGOING TREATMENT FOR ACUTE MYELOID LEUKAEMIA SHOWING HIGH DEGREE OF PREDICTIVE ACCURACY ON THE EUROPEAN LEUKAEMIA NET (ELN) POST-REMISSION TREATMENT SCORE

EHA Library, Michelle Richardson, 387020

COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.

EHA Library, Minerva Montalvo Saavedra, 387021

NOT ALL VARIANTS OF ACUTE PROMYELOCYTIC LEUKEMIAS ARE RESISTANT TO RETINOIDS.

EHA Library, Mehndi Dandwani, 387022

FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Uwe Platzbecker, 387023

THE PROGNOSTICATION  FACTORS IN DE NOVO AML PATIENTS IN A SINGLE CENTER: DO THEY HAVE DIFFERENCES THAN THE REPORTED DATA?

EHA Library, NAHLA IBRAHIM, 387024

CAN „CUP LIKE“ NUCLEAR CYTOMORPHOLOGY PREDICT NUCLEOPHOSMIN MUTATED STATUS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA?

EHA Library, Andrija Bogdanovic, 387025

REAL-WORLD EXPERIENCE OF LOW-DOSE VENETOCLAX WITH AZACITIDINE FOR UNFIT AML PATIENTS(≥60Y) WITH LOW LEUKOCYTE COUNT

EHA Library, Siyuan Cui, 387026

HYPOMETHYLATING AGENT PLUS LOW DOSE VENETOCLAX – A CHEMOTHERAPY-FREE INDUCTION OF ACUTE MYELOID LEUKEMIA TO ACHIEVE COMPLETE REMISSION IN PATIENTS UNFIT FOR CHEMOTHERAPY

EHA Library, Gaurav Dhingra, 387027

EPIDEMIOLOGICAL PROFILE AND DIAGNOSTIC FEATURES OF ACUTE MYELOBLASTIC LEUKEMIA IN ADULTS: EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX

EHA Library, Yousra Fakhfakh Derbel, 387028

NRF2 INHIBITION IN COMBINATION WITH IBRUTINIB IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA– AN IN VITRO STUDY

EHA Library, Ana Bela Sarmento-Ribeiro, 387029

LOW-BURDEN TP53 MUTATIONS REPRESENT FREQUENT GENETIC EVENTS IN CLL WITH AN INCREASED RISK FOR TREATMENT INITIATION

EHA Library, Tamás László, 387030

TELAGLENASTAT (CB-839) IN MONOTHERAPY AND IN COMBINATION WITH EPIGENETIC MODULATORS OR IBRUTINIB INDUCES CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Ana Bela Sarmento-Ribeiro, 387031

CYTOGENOMIC INTEGRATIVE ANALYSIS OF CLL/SLL PATIENTS AT DISEASE PROGRESSION.

EHA Library, Rocío García-Serra, 387032

BTK AND PLCG2 GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH RESISTANCE TO COVALENT BTK INHIBITOR

EHA Library, Ekaterina Likold, 387033

IGH 3’RR RECOMBINATION UNCOVERS A NON-GC IMPRINT AND C-MYC-DEPENDENT IGH REARRANGEMENT ACTIVITY IN UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sophie Peron, 387034